IL1B and cystic fibrosis: Moreover, in this article, the authors have also demonstrated that IL-8, IL-1β, and TNF-α (Tumor necrosis factor-α) decreased significantly in the serum of CF patients treated with Ivacaftor and Tezacaftor treatment.